Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low-grade gliomas

European Journal of Neurology

Volumn 19, Issue 2, 2012, Pages 298-306

  You, G ^a   Huang, L ^a   Yang, P ^a   Zhang, W ^a   Yan, W ^a   Wang, Y ^a   Bao, Z ^a   Li, S ^a,b   Li, G ^b   Jiang, T ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Engel class; Epilepsy; Extent of resection; Ki 67; LOH 19q; Low grade glioma; Seizure

Indexed keywords

GELATINASE B; KI 67 ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN CALCIFICATION; CANCER GRADING; CANCER SURGERY; CHINESE; CHROMOSOME 19Q; CHROMOSOME 1P; CLINICAL GENETICS; DISEASE CONTROL; FEMALE; FRONTAL LOBE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOMA; HETEROZYGOSITY LOSS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEIZURE; TEMPORAL LOBE; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES;

EID: 84856025767     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03509.x     Document Type: Article

References (33)

1. Chang EF, Potts MB, Keles GE, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008; 108: 227-235.
2. Danfors T, Ribom D, Berntsson SG, Smits A. Epileptic seizures and survival in early disease of grade 2 gliomas. Eur J Neurol 2009; 16: 823-831.
3. Lynam LM, Lyons MK, Drazkowski JF, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 2007; 109: 634-638.
4. Lee JW, Wen PY, Hurwitz S, et al. Morphological characteristics of brain tumors causing seizures. Arch Neurol 2010; 67: 336-342.
5. Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 2000; 142: 1-15.
6. Manna I, Labate A, Gambardella A, et al. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci Lett 2007; 421: 52-56.
7. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 1118-1126.
8. Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 2003; 20: 65-72.
9. Wiencke JK, Aldape K, McMillan A, et al. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNAalkyltransferase. Cancer Epidemiol Biomarkers Prev 2005; 14: 1774-1783.
10. Li S, Zhang W, Chen B, Jiang T, Wang Z. Prognostic and predictive value of P53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy. Neuro Res 2010; 32: 690-694.
11. Kanner AA, Staugaitis SM, Castilla EA, et al. The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making. J Neurosurg 2006; 104: 542-550.
12. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 2007; 68: 1831-1836.
13. Huang L, You G, Jiang T, Li GL, Li SW, Wang ZC. Correlation between tumor-related seizures and molecular genetic profile in 103 Chinese patients with low-grade gliomas: a preliminary study. J Neurol Sci 2011; 302: 63-67.
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC Press, 2007: 50-52.
15. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803.
16. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54: 91-95.
17. Chernova OB, Barnett GH, Cowell JK. Rapid detection of allelic losses in brain tumours using microsatellite repeat markers and high-performance liquid chromatography. Br J Cancer 2003; 88: 1889-1893.
18. Kleymenova E, Walker CL. Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC). J Biochem Biophys Methods 2001; 47: 83-90.
19. Chaichana KL, Parker SL, Olivi A, Quiñones-Hinojosa A. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg 2009; 111: 282-292.
20. Khan RB, Boop FA, Onar A, Sanford RA. Seizures in children with low-grade tumors: outcome after tumor resection and risk factors for uncontrolled seizures. J Neurosurg 2006; 104: 377-382.
21. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008; 63: 700-708.
22. Kim DW, Kim HK, LEE SK, Chu K, Chung CK. Extent of neocortical resection and surgical outcome of epilepsy: intracranial EEG analysis. Epilepsia 2010; 51: 1010-1017.
23. Prayson RA. Ki-67 immunoreactivity in type II malformations of cortical development. Appl Immunohistochem Mol Morphol 2008; 16: 357-361.
24. Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 2002; 115: 97-105.
25. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003; 62: 111-126.
26. Gourfinkel-An I, Baulac S, Nabbout R, et al. Monogenic idiopathic epilepsies. Lancet Neurol 2004; 3: 209-218.
27. Abad RS, Vilaplana FXS, Ferna′ndez JMS. Genetic causes of epilepsy. The Neurologist 2007; 13: S47-S51.
28. Gurnett CA, Hedera P. New ideas in epilepsy genetics: movel epilepsy genes, copy number alterations, and gene regulation. Arch Neurol 2007; 64: 324-328.
29. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus: a genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-490.
30. Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998; 19: 366-370.
31. Amatniek JC, Hauser WA, Castillo-Castaneda CD, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006; 47: 867-872.
32. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55: 435-437.
33. Yeni SN, Ozkara C, Buyru N, et al. Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol 2005; 12: 103-107.